STRATEC SE

M&A Activity • Dec 14, 2010

News Details

Corporate | 14 December 2010 10:08

STRATEC announces agreement with Abbott Diagnostics

STRATEC Biomedical Systems AG / Key word(s): Contract
STRATEC announces agreement with Abbott Diagnostics

14.12.2010 / 10:08

STRATEC announces agreement with Abbott Diagnostics

Birkenfeld, December 14, 2010

STRATEC Biomedical Systems AG, Birkenfeld, Germany (Frankfurt: SBS; Prime
Standard, TecDAX) today announced that it has signed an agreement with
Abbott Diagnostics, a division of Abbott Laboratories, Abbott Park,
Illinois, USA (NYSE: ABT).

The agreement covers the co-development of an analyzer system solution,
using STRATEC technology and provides further details about the
manufacturing and supply by STRATEC.

Development of the system has already begun as part of a feasibility study.
Further project and financial details have not been disclosed.

About STRATEC

STRATEC Biomedical Systems AG (www.stratec-biomedical.de) designs and
manufactures fully automated systems for its partners in the fields of
clinical diagnostics and biotechnology. These partners market such systems,
in general together with their own reagents, to laboratories, blood banks
and research institutes around the world. The company develops its products
on the basis of its own patented technologies. Shares in the company (ISIN:
DE0007289001) are traded in the Prime Standard segment of the Frankfurt
Stock Exchange, and are a constituent of the Deutsche Börse TecDAX.

The STRATEC Group consists of the publicly listed parent company STRATEC
Biomedical Systems AG and of subsidiaries and second-tier subsidiaries in
Germany, the USA, the UK, Switzerland and Romania.

Further information can be obtained from:

STRATEC Biomedical Systems AG
André Loy, Investor Relations
Gewerbestr. 37, 75217 Birkenfeld
Germany
Phone: +49 7082 7916 190
Fax: +49 7082 7916 999
ir@stratec-biomedical.de
www.stratec-biomedical.de

End of Corporate News

14.12.2010 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: STRATEC Biomedical Systems AG
Gewerbestraße 37
75217 Birkenfeld
Deutschland
Phone: +49 (0)7082 7916 0
Fax: +49 (0)7082 7916 999
E-mail: info@stratec-biomedical.de
Internet: www.stratec-biomedical.de
ISIN: DE0007289001
WKN: 728900
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart

End of News DGAP News-Service

106362 14.12.2010